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A Fluoro-Deoxy-Glucose, Positron Emission
Tomography fused with computed tomography
scan is recommended for detecting undiagnosed
primary and/or metastatic carcinoma.
Case report
A 27-year-old southern Chinesewoman presented
with a 2-year history of painless left-sided parotid
mass with no other symptoms, past medical or
family history.
Initial ﬁne-needle-aspiration cytology demon-
strated lymphoid tissue inﬁltrated by atypical
cells with Epstein-Barr virus encoded RNA
(EBER) positivity. This raised the possibility of
lymphoma, so a superﬁcial parotidectomy for his-
tological diagnosis was performed.
Histopathological analysis demonstrated
lympho-ﬁbroadipose tissue inﬁltrated by tumour
typical for lymphoepithelial carcinoma. The neo-
plastic cells expressed pancytokeratin AE1/AE3
and were EBER positive (Figure 1). There was no
identiﬁable surrounding normal tissue suggesting
whether this arose within the gland oran intrapar-
otid lymph node.
Given her ethnicity, undifferentiated carcinoma
of the nasopharyngeal type (UCNT) with nodal
metastases was suspected. An examination-under-
anaesthesia with nasopharyngeal biopsy to elicit
the primary site was performed but no malignancy
was evidenced.
A MRI scan had shown a multifocal left intra-
parotid mass. A ﬂuoro-deoxy-glucose, positron
emission tomography fused with computed
tomography (FDG, PET-CT) scan from the skull
base to the upper thighs depicted this mass with
small-volume regional nodes (Figure 2).
Altogether, there were no features suggesting a
mucosal primary. Primary lymphoepithelial carci-
noma of the parotid or metastatic UCNT of
unknown primary origin was the differential
diagnosis.
Discussion
Nasopharyngeal carcinoma (NPC) usually pre-
sents as an unknown primary following metasta-
sis to cervical nodes in 40–70% of patients.
1,2
Local pressure effects of the tumour may result
in otitis media- from Eustachian tube obstruction,
epistaxis or rarely cranial nerve palsies. Lymphoe-
pithelial carcinoma, a rare variant of UCNT (one
of three subtypes of NPC) accounts for less than
0.5% of all salivary gland malignancies.
1
Lymphoepithelial carcinoma has typical histo-
pathological features (see ﬁgure 1) and conﬁrma-
tory EBER expression by chromogenic in situ
hybridisation is demonstrated in this case.
Usually the primary tumour arises in the naso-
pharynx, especially in southern China where inci-
dence is reported as up to 80 times higher than in
the Western World.
2 Seventy ﬁve percent of those
affected reportedly originate from south east
China.
1 The association between certain human
leucocyte antigen (HLA) types,
3 the southern
Chinese diet
2,3 and evidence of infection with
Epstein Barr virus (EBV)
2,3,4 in the pathogenesis
of UCNT is well documented. There have also
been reports describing rare cases involving the
lungs, thymus, larynx, trachea, soft palate and
skin.
1
Metastases from nasopharyngeal carcinoma are
occasionally seen in the parotid gland, especially
with a tumour extending into the eustachian
tube, with access to the intraparotid lymphatics.
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CASE REPORT
1In this case, assessments failed to demonstrate a
mucosal primary tumour. The multifocal intrapar-
otid deposits (Figure 2) also heightened the suspi-
cion that these were metastases.
Primary lymphoepithelial carcinoma of the
parotid was considered, consistent with the radio-
logical ﬁndings of tumour conﬁned to the parotid
gland. The patient’s ethnicity, multifocal disease
and its extreme rarity,
5 suggested that this was
unlikely.
FDG, PET-CT has been widely recommended
as sensitive at detecting both primary malignancy
and metastatic spread previously undiagnosed by
other modalities.
4,6,7 It has been linked to a
number of false-positive results.
8 Whilst it has a
very low false-negative rate, it does not exclude
small mucosal primaries.
An intraparotid nodal metastasis from a lym-
phoepithelial carcinoma of unidentiﬁed mucosal
primary site was felt to be the most likely diagno-
sis. Nasopharyngeal UCNT nodal metastasis
occurs most commonly to the retropharyngeal
node (of Rouvie `re) ﬁrst, and then to level II and
level V.
2 There are three possible mechanisms to
explain primary UCNT spread to the parotid,
9
raising the possibility of an unidentiﬁed eusta-
chian tube mucosa primary UCNT.
Radiotherapy has been the mainstay of treat-
ment of nasopharyngeal carcinoma due to its
radiosensitivity. It is therefore important to dis-
tinguish between primary parotid UCNT tumour
and secondary parotid UCNT. Should the
parotid be irradiated alone or should candidate
mucosal surfaces also be targeted? If a nasophar-
yngeal carcinoma with metastasis to the salivary
gland is treated as a primitive tumour of the
parotid, the correct radiotherapy to the primary
site will not be administered.
1
She is currently receiving systemic chemother-
apy with targeted adjuvant radiotherapy, as this
is associated with high levels of local tumour
control. Other therapy modalities include super-
ﬁcial parotidectomy with either neck dissection
or the preferred adjuvant radiotherapy alone.
Due to the rarity of this condition, the evidence
supporting therapy is limited.
1 One report esti-
mated 2-, 5- and 10 year survival at 91%, 66%
and 29% respectively for lymphoepithelial carci-
noma of the salivary glands.
10 Further research is
needed to determine the effect of different treat-
ment modalities on survival.
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